World Point of Care Diagnostics Market Size and Market Share Analysis

  • ID: 4395558
  • Report
  • Region: Global
  • 401 Pages
  • Kalorama Information
1 of 7

FEATURED COMPANIES

  • Abaxis
  • Ativa Medical Corp
  • biOracle Limited
  • Enterix
  • LifeSign
  • Polymer Technologies
  • MORE

This research estimates the point of care diagnostics testing market at $18.4 billion, according to our latest market research study conducted this year. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the point of care diagnostic market. The driving force behind these innovations in healthcare is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostics industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine. Globally, millions of dollars are spent annually on point of care diagnostic testing, both professional testing and self-testing.

What's the size of the market opportunity in each rapid and near-patient diagnostic testing segment? Who's winning in point of care diagnostics market share? This updated superior resource, World Point of Care Diagnostics Market Size and Market Share Analysis, focuses on the global market for point of care diagnostics.

In-Depth Point of Care Diagnostics Market Information, including:

  • Market Sizes and Market Share by Test Segment
  • Global Market Data
  • Over 80 Detailed Profiles of POC Testing Companies
  • Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2016
  • Global POC Testing Market Analysis by Product Category, 2016 (Professional, Self-Testing)
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2016 (Drugs of Abuse, Blood & Electrolytes, Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Lipid, Pregnancy & Fertility, Miscellaneous, Urine Strip, Cancer, Total)
  • Global POC Self-Testing Market Analysis by Product Category, 2016 (Glucose, Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Lipid)
  • POC Testing Analysis by Region/Country, 2016 (United States, Europe, Japan, ROW, Total)
  • POC Testing Market Analysis by European Region, 2016 (Germany, France, UK, Italy, Spain, Others)
  • POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other, Total)

This report, World Point of Care Diagnostics Market Size and Market Share Analysis, features in-depth analysis of the market for the traditional set of point of care diagnostics tests: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more decentralized test venues invest in non-waived rapid tests and instruments POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.

Who is Leading Point of Care Testing?

Roche, Alere, Abbott, and Siemens are among the largest companies in point of care (POC) diagnostics in terms of revenues. Together these companies make up three-fourths of the entire point of care diagnostics market. Point of care systems are designed to deliver test results in a location and timing to be useful during a patient visit. They consist of devices such as glucose meters operated by a patient or small analyzers operated in a physician office lab.

Roche dominated the point of care diagnostics market as it does in several other in IVD (in vitro diagnostics) categories.  Coagulation and glucose testing are key areas. In June 2015, Roche introduced the cobas c 513 blood glucose analyzer. It is a dedicated, high-throughput HbA1c analyzer suitable for diagnosis, monitoring and risk identification of diabetes patients.

Waltham, MA-based Alere secured the second market position Alere participates in nearly all POC test segments but has a dominating position in rapid cardiac markers.

World Point of Care Diagnostics Market Size and Market Share Analysis' geographic scope is worldwide with information for specific geographical regions; world demographics, and other general issues affecting the point of care testing market. The market summary includes market analysis by product and region and a competitive analysis of leading POC providers. Large and small companies are involved in the development and/or marketing of POC testing. The market is considered evolving with growth opportunity. Developing and developed markets alike have room to grow due to an aging population worldwide.

Issues & Trends Affecting the Point of Care Diagnostics Testing Market include:

  • Wearables
  • Breath Test Advances
  • Reimbursement Challenges
  • Competition
  • POC and Molecular Diagnostics
  • POC and Biosensors and Microfluidics
  • POC Connectivity
  • The Emergence of Non-invasive Technologies
READ MORE
Note: Product cover images may vary from those shown
2 of 7

FEATURED COMPANIES

  • Abaxis
  • Ativa Medical Corp
  • biOracle Limited
  • Enterix
  • LifeSign
  • Polymer Technologies
  • MORE

1: EXECUTIVE SUMMARY

  • Introduction
  • Scope And Methodology
  • Size And Growth Of The Market
    • Table 1-1: Global POC Test Market, 2014-2021
  • Trends Affecting The Market
  • Competitive Outlook

2: INTRODUCTION AND OVERVIEW

  • POINT-OF-CARE DIAGNOSTICS TESTING
  • INDUSTRY REGULATIONS
  • POC INDUSTRY DRIVERS
    • Patient focused drivers
    • Medical/Healthcare related drivers
    • Technology drivers
    • Economic drivers
    • Other drivers
  • POC TEST TYPES
    • Blood
    • Urine
    • Saliva
    • Hair
    • Optical Technologies
    • Breath
  • CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING
    • Cancer
    • Cardiovascular Disease
    • Diabetes
    • Drug Abuse
    • Central Nervous System Stimulants
    • Prevalence and Number of Illicit Drug Users
    • Table 2-1: Estimated Number and Prevalence of Drug Users by Region and Age (15-64) (Africa, North America, South America, Asia,
    • Europe, Oceania, Global Total)
    • Infectious Disease
    • Pregnancy and Fertility
    • World Demographics
    • Table 2-2: World Population by Selected Geographical Region, 2010 - 2050 (Africa, Asia, Europe, North America, Oceania, Latin
    • America, World)
    • Global Aging Population

3: POC  BLOOD GLUCOSE TESTS

  • TYPES OF BLOOD GLUCOSE TESTING
    • Fasting Blood Sugar (FBS)
    • 2-Hour Postprandial Blood Sugar (PPBS)
    • Random Blood Sugar
    • Glucose Tolerance Test
    • Glucose Urine Test
    • Glycated Hemoglobin (HbA1c)
  • PRODUCTS
    • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
    • Continuous Self-Testing
    • Glycated Hemoglobin Tests
    • Professional
  • MARKET SIZE AND GROWTH IN GLUCOSE
  • POC Glucose Self-Testing
  • POC Glucose Professional Testing
  • MARKET SHARE ANALYSIS - POC GLUCOSE MARKET
    • Figure 3-1: Global POC Glucose Test Manufacturers by Percent, 2016

4: POC BLOOD AND ELECTROLYTES TESTING MARKET

  • TYPES OF BLOOD AND ELECTROLYTES TESTS
    • Hemoglobin/Hematocrit
  • WBC
    • Blood Gases
    • Electrolytes
  • PRODUCTS
    • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2016
    • Table 4-2: Selected POC Hematology Analyzer Systems, 2016
  • MARKET SIZE AND GROWTH
    • Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2014-2021
  • POC Blood and Electrolyte Self-Testing
  • POC Blood and Electrolyte Professional Testing
    • Table 4-4: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2016-2021
  • MARKET SHARE ANALYSIS IN BLOOD AND ELECTROLYTE TESTING
    • Table 4-5: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 4-1: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2016

5: POC RAPID COAGULATION

  • PRODUCTS
    • Table 5-1: Selected POC Coagulation Innovations
    • Platelet Testing
    • Table 5-2: Selected Platelet Activity Test Innovations
  • MARKET SIZE AND GROWTH
    • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2014-2021
  • POC Rapid Coagulation Self-Testing
    • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2016-2021
  • POC Rapid Coagulation Professional Testing
    • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2016-2021
  • MARKET SHARE ANALYSIS IN COAGULATION TESTING
    • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 5-1: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2016

6: POC RAPID CARDIAC MARKERS

  • PRODUCTS
  • MARKET SIZE AND GROWTH
    • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2016-2021
  • MARKET SHARE ANALYSIS
    • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2016 (in millions $)
    • Figure 6-1: Global POC Cardiac Test Manufacturers by Percent, 2016

7: POC DRUG TESTING

  • PRODUCTS
    • Urine
    • Oral
    • Blood
    • Hair
  • MARKET SIZE AND GROWTH
  • POC Drugs of Abuse Self-Testing
  • POC Drugs of Abuse Professional Testing
  • MARKET SHARE ANALYSIS IN DRUG ABUSE TESTING
    • Table 7-1: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 7-1: Global POC Drug of Abuse Testing Manufacturers by Percent, 2016

8: POC PREGNANCY AND FERTILITY TESTING

  • PRODUCTS
    • Table 8-1: 2016 Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device /Assay
  • MARKET SIZE AND GROWTH
    • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2014-2021
  • POC Pregnancy and Fertility Self-Testing
    • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2016-2021
  • POC Pregnancy and Fertility Professional Testing
    • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2016-2021
  • MARKET SHARE ANALYSIS IN PREGNANCY TESTING
    • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2016
    • Figure 8-1: Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2016

9: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

  • PRODUCTS
    • Table 9-1: Selected POC Colon Cancer Tests
  • MARKET SIZE AND GROWTH
    • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2014-2021 .. 119
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
    • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2016-2021
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
    • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2014-2019 (in millions of dollars)
  • MARKET SHARE ANALYSIS IN POC COLON CANCER SCREENING
    • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers,2016
    • Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (%), 2016

10: POC INFECTIOUS DISEASE TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
  • POC Infectious Disease Self-Testing
  • POC Infectious Disease Professional Testing
  • COMPETITIVE ANALYSIS
    • Figure 10-1: Global POC Infectious Disease Test Manufacturers by Percent, 2016

11: POC CHOLESTEROL TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
  • Table 11-1: Global POC Cholesterol Testing Market Analysis, 2014-2021
  • POC Cholesterol Self-Testing
  • Table 11-2: POC Cholesterol Self-Testing Market Analysis, 2016-2021
  • POC Cholesterol Professional Testing
  • Table 11-3: POC Cholesterol Professional Testing Market Analysis, 2016-2021
  • MARKET SHARE ANALYSIS IN POC CHOLESTEROL TESTING
  • Table 11-4: Global POC Cholesterol Testing Market, Revenues and Market Share of Leading Suppliers, 2016 (in millions $)
  • Figure 11-1: Global POC Cholesterol Testing Manufacturers by Percent, 2016

12: POC CANCER TUMOR MARKER TESTING

  • PRODUCTS
    • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • MARKET SIZE AND GROWTH
    • Table 12-2: Global POC Cancer Testing Market Analysis, 2014-2021
  • MARKET SHARE ANALYSIS IN GLOBAL POC CANCER TUMOR TESTING
    • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2016 . 142
    • Figure 12-1: Global POC Cancer Testing Manufacturers by Percent, 2016

13: POC URINE STRIP TESTING

  • PRODUCTS
  • MARKET SIZE AND GROWTH
  • POC Urine Strip Self-Testing
  • POC Urine Test Strip Professional Testing
  • COMPETITIVE ANALYSIS
    • Figure 13-1: Global POC Urine Strip Testing Manufacturers by Percent, 2016

14: MISCELLANEOUS POC TESTING

  • MICROBIOLOGY
  • TSH
  • ALLERGY
  • AUTOIMMUNE
  • OTHERS
  • MARKET SIZE AND GROWTH
    • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2014-2021

15: ISSUES AND TRENDS IN POINT OF CARE

  • OVERVIEW
    • The World Market for Point of Care Diagnostics
  • WEARABLES
    • Table 15-1: Selected Wearable Devices
  • BREATH TEST ADVANCES
    • Table 15-2: Selected Disease Markers in Exhaled Breath
  • REIMBURSEMENT CHALLENGES
  • COMPETITION
  • POC AND MOLECULAR DIAGNOSTICS
    • Table 15-3: Market Available Molecular POC Diagnostic Platforms
  • POC AND BIOSENSORS AND MICROFLUIDICS
    • Table 15-4: Selected Biochip and Biosensor Players, 2016
  • POC CONNECTIVITY
  • THE EMERGENCE OF NON-INVASIVE TECHNOLOGIES
    • Saliva and Swab
    • Optical Techniques

16: OVERALL GLOBAL POC TESTING MARKET AND MARKET SHARE ANALYSIS

  • MARKET OVERVIEW
    • Table 16-1: Global POC Test Market, 2014-2021
  • MARKET ANALYSIS BY PRODUCT CATEGORIES
    • Table 16-2: Global POC Testing Market Analysis by Product Category, 2016 (Professional, Self-Testing) .. 176
  • MARKET ANALYSIS BY SUBCATEGORY
  • POC Professional Testing
    • Table 16-3: Global POC Professional Testing Market Analysis by Product Subcategory, 2016 (Drugs of Abuse, Blood & Electrolytes,Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Lipid, Pregnancy & Fertility, Miscellaneous, UrineStrip, Cancer, Total)
  • POC Self-Testing
    • Table 16-4: Global POC Self-Testing Market Analysis by Product Category, 2016 (Glucose, Pregnancy & Fertility, Fecal Occult Blood,
    • Rapid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Lipid)
  • MARKET ANALYSIS BY COUNTRY
    • United States
    • Europe
    • Japan
    • Rest of World
    • Table 16-5: Global POC Testing Analysis by Region/Country, 2016 (United States, Europe, Japan, ROW, Total)
    • Figure 16-1: Global POC Testing Market Analysis Percent by Region/Country, 2016 (United States, Europe, Japan, ROW)
    • Table 16-6: Global POC Testing Market Analysis by European Region, 2016 (W. Europe, E. Europe)
    • Figure 16-2: Global POC Testing Market Analysis by European Region, 2016 (Germany, France, UK, Italy, Spain, Others)
    • Table 16-7: Global POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other, Total)
    • Figure 16-3: Global POC Testing Market Analysis by Rest of World Region/Country, 2016 (China, India, Brazil, Other)
  • MARKET CONCLUSIONS
    • Conclusion One
    • Conclusion Two
    • Conclusion Three
    • Conclusion Four
    • Conclusion Five
    • Conclusion Six
  • MARKET SHARE ANALYSIS
    • Table 16-8: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2016
    • Figure 16-4: Global POC Testing Market Share by Leading Suppliers, 2016

17: CORPORATE PROFILES
OVERVIEW
ABAXIS, INC.
Table 17-1: Abaxis Corporate Summary
Company Overview
Products
Performance Review
Table 17-2: Abaxis Revenue (2013-2016)
ABBOTT LABORATORIES
Table 17-3: Abbott Corporate Summary
Company Overview
Product
Performance Review
Table 17-4: Abbott Laboratories Revenue (2013-2016)
ABINGDON HEALTH, LTD.
Table 17-5: Abingdon Health Corporate Summary
Company Overview
Products
ACCUBIOTECH CO, LTD.
Table 17-6: AccuBioTech Summary
Company Overview
Products
ACCRIVA DIAGNOSTICS
Table 17-7: Accriva Diagnostics Summary
Company Overview
Products
ACON LABORATORIES, INC
Table 17-8: ACON Laboratories Corporate Summary
Company Overview
Products
AERSCHER DIAGNOSTICS, LLC
Table 17-9: Aerscher Diagnostics Summary
Company Overview
Products
ALERE INC
Table 17-10: Alere Corporate Summary
Company Overview
Product
Performance Review
Table 17-11: Alere Revenue (2013-2016)
ALFA SCIENTIFIC DESIGNS, INC
Table 17-12: Alfa Scientific Summary
Company Overview
Products
AMERICAN BIO MEDICA CORPORATION
Table 17-13: American Bio Medica Summary
Company Overview
Products
AQUILA DIAGNOSTIC SYSTEMS, INC
Table 17-14: Aquila Diagnostic Systems Summary
Company Overview
ARKRAY
Table 17-15: Arkay Corporate Summary
Company Overview
Products
ARTRON LABORATORIES, INC
Table 17-16: Artron Laboratories Summary
Company Overview
ATLAS GENETICS LTD.
Table 17-17: Atlas Genetics Corporate Summary
Company Overview
Products
ATLAS LINK BIOTECH CO., LTD
Table 17-18: Atlas Link Biotech Summary
Company Overview
ATIVA MEDICAL CORPORATION
Table 17-19: Ativa Medical Summary
Company Overview
AUTOBIO DIAGNOSTICS CO., LTD
Table 17-20: Autobio Summary
Company Overview
AUGURIX DIAGNOSTIC
Table 17-21: Augurix Diagnostic Summary
Company Overview
AXXIN
Table 17-22: Axxin Summary
Company Overview
BECKMAN COULTER, INC
Table 17-23: Beckman Coulter Corporate Summary
Company Overview
Products
Performance Review
Table 17-24: Beckman Coulter (2013-2016)
BIOLYTICAL LABORATORIES
Table 17-25: bioLytical Laboratories Summary
Company Overview
BIOMERICA
Table 17-26: Biomerica Summary
Company Overview
BIOPTIX, INC
Table 17-27: Bioptix Summary
Company Overview
BIORACLE LIMITED
Table 17-28: biOracle Summary
Company Overview
BIOMEDOMICS, INC
Table 17-29: BioMedomics Summary
Company Overview
BIOMEME, INC
Table 17-30: Biomeme Corporate Summary
Company Overview
BIOMERIEUX SA
Table 17-31: bioMerieux SA Corporate Summary
Company Overview
Products
Performance Review
Table 17-32: bioMerieux Revenues (2013-2016)
BIOSENSIA
Table 17-33: Biosensia Summary
Company Overview
CALYPTE BIOMEDICAL CORPORATION
Table 17-34: Calypte Biomedical Summary
Company Overview
CEPHID
Table 17-35: Cephid Corporate Summary
Company Overview
Products
Performance Review
Table 17-36: Cephid Revenues (2013-2016)
CHEMBIO DIAGNOSTIC SYSTEMS, INC.
Table 17-37: Chembio Diagnostic Corporate Summary
Company Overview
Products
Performance Review
Table 17-38: Chembio Diagnostics Revenues (2013-2016)
CHURCH & DWIGHT CO. INC
Table 17-39: Church & Dwight Corporate Summary
Company Overview
Products
Performance Review
Table 17-40: Church & Dwight Revenue (2013-2016)
DAKTARI DIAGNOSTICS
Table 17-41: Daktari Diagnostics Summary
Company Overview
DANAHER CORPORATION
Table 17-42: Danaher Corporation Summary
Company Overview
DEXCOM, INC
Table 17-43: DexCom Summary
Company Overview
Products
Performance Review
Table 17-44: DexCom Revenue (2013-2016)
DNA ELECTRONICS LTD. (DNAE)
Table 17-45: DNA Electronics Corporate Summary
Company Overview
DRAGERWERK AG & CO. KGAA
Table 17-46: Dragerwerk Corporate Summary
Company Overview
Products
Company Financials
Table 17-47: Drager Revenue (2013-2016)
EIKEN CHEMICAL CO LTD.
Table 17-48: Eiken Chemical Corporate Summary
Company Overview
Products
Performance Review
Table 17-49: Eiken Chemical Revenue (2013-2016)
EKF DIAGNOSTICS HOLDINGS PLC
Table 17-50: EKF Diagnostics Corporate Summary
Company Overview
Products
Performance Review
Table 17-51: EKF Diagnostics Revenue (2013-2016)
ENIGMA DIAGNOSTICS, LTD.
Table 17-52: Enigma Diagnostics Corporate Summary
Company Overview
Products
ENTERIX, INC
Table 17-53: Enterix Corporate Summary
Company Overview
Products
ENTOPSIS
Table 17-54: Entopsis Corporate Summary
Company Overview
Products
EPISTEM/GENEDRIVE
Table 17-55: Epistem/Genedrive Corporate Summary
Company Overview
Products
EY LABORATORIES
Table 17-56: EY Laboratories Summary
Company Overview
EXALENZ BIOSCIENCE LTD.
Table 17-57: Exalenz Bioscience Summary
Company Overview
FABPULOUS B.V.
Table 17-58: FABPulous Corporate Summary
Company Overview
Products
FIO CORPORATION
Table 17-59: Fio Corporate Summary
Company Overview
Products
HELENA LABORATORIES
Table 17-60: Helena Laboratories Corporate Summary
Company Overview
Products
HEMA DIAGNOSTIC SYSTEMS, LLC
Table 17-61: Hema Diagnostics Systems Corporate Summary
Company Overview
Products
INSILIXA, INC
Table 17-62: InSilixa Corporate Summary
Company Overview
Products
INSTRUMENTATION LABORATORY
Table 17-63: Instrumentation Laboratory Corporate Summary
Company Overview
Products
JANT PHARMACAL CORPORATION
Table 17-64: Jant Pharmacal Summary
Company Overview
Products
LAMDAGEN CORPORATION
Table 17-65: LamdaGen Corporate Summary
Company Overview
LIFESCAN, INC
Table 17-66: LifeScan Corporate Summary
Company Overview
Products
Performance Review
Table 17-67: LifeScan Revenue (2013-2016)
LIFESIGN, LLC
Table 17-68: LifeSign Summary
Company Overview
MACHEREY-NAGEL GMBH & CO. KG
Table 17-69: Macherey-Nagel Corporate Summary
Company Overview
Products
MAGNASENSE TECHNOLOGIES
Table 17-70: Magnasense Technologies Summary
Company Overview
MBIO DIAGNOSTICS, INC
Table 17-71: Mbio Diagnostics Summary
Company Overview
MEDIX BIOCHEMICA
Table 17-72: Medix Biochemica Summary
Company Overview
Products
MEDMIRA, INC
Table 17-73: MedMira Corporate Summary
Company Overview
Products
Performance Review
Table 17-74: MedMira Revenue (2013-2016)
MENARINI DIAGNOSTICS
Table 17-75: Menarini Diagnostics Summary
Company Overview
Products
MERIDIAN BIOSCIENCE, INC
Table 17-76: Meridian BioScience Corporate Summary
Company Overview
Products
Performance Review
Table 17-77: Meridian Bioscience Revenue (2013-2016)
METAARA MEDICAL TECHNOLOGIES, INC
Table 17-78: Metaara Medical Technologies Summary
Company Overview
MICRONICS, INC
Table 17-79: Micronics Summary
Company Overview
NOVA BIOMEDICAL, CORP.
Table 17-80: Nova Biomedical Corporate Summary
Company Overview
Products
OPKO HEALTH, INC
Table 17-81: OPKO Health Corporate Summary
Company Overview
Products
Performance Review
Table 17-82: OPKO Health Revenue (2013-2016)
ORASURE TECHNOLOGIES, INC.
Table 17-83: OraSure Technologies Corporate Summary
Company Overview
Products
Performance Review
Table 17-84: OraSure Revenue (2013-2016)
ORTHO CLINICAL DIAGNOSTICS
Table 17-85: Ortho Clinical Diagnostics Corporate Summary
Company Overview
Products
Performance Review
Table 17-86: Ortho Clinical Diagnostics Revenue (2013-2016)
POLYMED THERAPEUTICS INC.
Table 17-87: Polymed Therapeutics Corporate Summary
Company Overview
Products
POLYMEDCO, INC
Table 17-88: Polymedco Corporate Summary
Company Overview
Products
POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)
Table 17-89: Polymer Technologies Corporate Summary
Company Overview
Products
QUANTUMDX GROUP LIMITED
Table 17-90: QuantuMDx Group Corporate Summary
Company Overview
Products
QUIDEL CORPORATION
Table 17-91: Quidel Corporate Summary
Company Overview
Products
Performance Review
Table 17-92: Quidel Revenue (2013-2016)
RADIOMETER MEDICAL A/S
Table 17-93: Radiometer Medical Corporate Summary
Company Overview
Products
Performance Review
Table 17-94: Radiometer Revenue (2013-2016)
RESPONSE BIOMEDICAL CORP
Table 17-95: Response Biomedical Corporate Summary
Company Overview
Products
Performance Review
Table 17-96: Response Biomedical Revenue (2013-2016)
RHEONIX, INC
Table 17-97: Rheonix Corporate Summary
Company Overview
Products
ROCHE DIAGNOSTIC CORPORATION
Table 17-98: Roche Corporate Summary
Company Overview
Products
Performance Review
Table 17-99: Roche Revenue (2013-2016)
SAMSUNG HEALTHCARE
Table 17-100: Samsung Healthcare Corporate Summary
Company Overview
Products
SAVYON DIAGNOSTICS
Table 17-101: Savyon Diagnostics Summary
Company Overview
Products
SEKISUI DIAGNOSTICS
Table 17-102: Sekisui Diagnostics Summary
Company Overview
Products
SIEMENS HEALTHINEERS
Table 17-103: Siemens Healthineers Corporate Summary
Company Overview
Products
Performance Review
Table 17-104: Siemens Healthineers Revenue (2013-2016)
SILOAM BIOSCIENCES, INC
Table 17-105: Siloam Biosciences Summary
Company Overview
Products
SPECTRAL MEDICAL, INC
Table 17-106: Spectral Medical Summary
Company Overview
SYSMEX CORPORATION
Table 17-107: Sysmex Corporate Summary
Company Overview
Products
Performance Review
Table 17-108: Sysmex Revenue (2013-2016)
TRINITY BIOTECH PLC
Table 17-109: Trinity Biotech Corporate Summary
Company Overview
Products
Performance Review
Table 17-110: Trinity Biotech Revenue (2013-2016)
VEREDUS LABORATORIES PTE LTD
Table 17-111: Veredus Labs Corporate Summary
Company Overview
Products
WAVE 80 BIOSCIENCES
Table 17-112: Wave 80 Biosciences Summary
Company Overview
XAGENIC
Table 17-113: Xagenic Corporate Summary
Company Overview
Products

Note: Product cover images may vary from those shown
3 of 7

Loading
LOADING...

4 of 7

FEATURED COMPANIES

  • Abaxis
  • Ativa Medical Corp
  • biOracle Limited
  • Enterix
  • LifeSign
  • Polymer Technologies
  • MORE
POC Market Trend: Molecular Diagnostics

The year 2015 was a game changer for point of care and molecular diagnostics. Prior to this time, molecular diagnostics were conducted in core labs. In January 2015, FDA granted Alere  its first CLIA waiver for a nucleic acid-based test, i Influenza A&B. This was followed by Roche’s CLIA waiver for the cobas Liat System and Strep A. By the beginning of 2016, many more systems also received CLIA waivers including Cepheid’s Xpert Flu+RSV Xpress. 

It is anticipated that many more companies will rush to develop new products for POC molecular diagnostic testing. Advances and innovations in microfluidics; isothermal and other alternative amplification chemistries; test automation; primers and probes; and nextgeneration sequencing (NGS) methods have been the most significant to the development of decentralized molecular diagnostics. In many cases, these technologies work together to facilitate clinical molecular testing in an automated manner within a smaller device.

POC Market Trend: Connectivity

Connectivity is an important aspect of the POC market.  The healthcare team needs to have  access to results to make timely care decisions. The EHR allows for quicker diagnosis and treatment.  Connectivity in POC testing has transcended the interface between device and user or computer to now support the integration of POC and POL testing results in greater laboratory information and health information systems (LIS/HIS). Healthcare consolidation has intensified demand for data and results availability from POC testing on organization systems that can be shared among clinics, hospitals, and affiliated laboratories. Suppliers of POC testing products and third-party vendors have appropriately standardized POC instrument-desktop/laptop computer connectivity, complete with data management software or features, and have developed solutions for data conversion and availability on same-party and third-party information systems. Continued consolidation in healthcare systems and mounting pressure to coordinate care and eliminate unnecessary repeat.

POC Market Trend: Saliva Testing

Numerous researchers have explored saliva testing as a means of detecting oral cancer. The principal market for oral cancer testing is in dentistry, where biopsies are drawn from mouth tissue for analysis by a pathologist. In San Antonio, a team of researchers from Rice University have developed a prototype lab-on-a-chip or biochip test for oral cancer using a swabbed oral saliva sample. An associated study found that the developed rapid test showed comparable rates of accuracy in detecting cancer and determining malignant and premalignant lesions as biopsied pathology tests. Another professor at Michigan State University is cooperating with PeriRx to perform FDA trials for a similar saliva test using oral cancer biomarkers.

Salivary hormone testing has also been used to assess insulin resistance, breast cancer, thyroid dysfunction, polycystic ovary disease, adrenal dysfunction, estrogen dominance and androgen deficiency. Most of these tests are promoted directly to consumers. Such tests are not covered under government health insurance plans or private insurers. There are hundreds of labs worldwide that offer saliva and buccal swab assays for hormones and molecular analysis. However, such tests are generally absent from POC portfolios and like most home testing services have come under scrutiny from the FDA, dissuading many physicians from implementing the tests.
The U.S. National Center for Dental and Craniofacial Research, part of the National Institutes of Health (NIH), is funding a project to create a catalog of all the proteins in saliva, called the Salivary Proteome Program, which should encourage the future development of salivary diagnostic tests.  By determining the normal ranges of proteins in saliva, researchers can develop tests to detect abnormal protein levels.

Researchers in the UCLA Human Salivary Proteome Project have made progress in proteomic cataloging, although significant work remains before a comprehensive catalogue of salivary secretory proteins – achieved using all available analytical methods – is compiled. The delay in diagnostic product development is rooted in the technical difficulty in developing adequately sensitive and specific tests for salivary analytes, which could compete with established blood-based cancer and other disease tests (excluding inherent salivary market test applications, such as for oral cancer).

Point of Care Market Trend: Optical Techniques

Many advances in optical testing of diagnostic samples have come in the fields of flow cytometry, hematology, and histology or anatomic pathology including digital pathology
technologies.. However, widely diverse diagnostic markers remain that do not require high complexity fluorescence staining such as molecular in-situ hybridization (ISH) or advanced immunodiagnostics. Visual or optical confirmation of results via fluorescence in other simpler immunodiagnostic formats is available to POC testing. Optical techniques for the characterization and detection of pre-cancerous lesions in the cervix and gastrointestinal or colorectal tract are of greatest relevance to POC markets. Such applications are aimed at mitigating or minimizing biopsy procedures and the general displacement of invasive procedures that are not necessarily any more successful in cancer screening and carry many added costs for health care.

Point-of-Care Market Trend: Connectivity

Connectivity is an important aspect of the POC market.  The healthcare team needs to have  access to results to make timely care decisions. The EHR allows for quicker diagnosis and treatment.  Connectivity in POC testing has transcended the interface between device and user or computer to now support the integration of POC and POL testing results in greater laboratory information and health information systems (LIS/HIS). Healthcare consolidation has intensified demand for data and results availability from POC testing on organization systems that can be shared among clinics, hospitals, and affiliated laboratories. Suppliers of POC testing products and third-party vendors have appropriately standardized POC instrument-desktop/laptop computer connectivity, complete with data management software or features, and have developed solutions for data conversion and availability on same-party and third-party information systems. Continued consolidation in healthcare systems and mounting pressure to coordinate care and eliminate unnecessary repeat.
Note: Product cover images may vary from those shown
5 of 7
  • Abaxis
  • Abbott Labs
  • Abingdon Health
  • Accriva
  • AccuBioTech Co
  • ACON
  • Aerscher Diagnostics
  • Alere
  • Alfa Scientific Designs
  • American Bio Medica
  • Aquila Diagnostic System
  • Arkray
  • Artron Laboratories
  • Ativa Medical Corp
  • Atlas Genetics
  • Atlas Link Biotech
  • Augurix Diagnostic
  • Autobio Diagnostics
  • Axxin
  • Beckman Coulter
  • bioLytical Laboratories
  • BioMedomics
  • Biomeme
  • Biomerica
  • bioMerieux SA
  • Bioptix
  • biOracle Limited
  • Biosensia
  • Calypte Biomedical Corp
  • Cephid
  • Chembio Diagnostic Systems
  • Church & Dwight
  • Dakaria Diagnostics
  • Danaher Corporation
  • DexCom
  • DNA Electronics
  • Dragerwerks
  • Eiken Chemical
  • EKF Diagnostics
  • Enigma Diagnostics
  • Enterix
  • Entopsis
  • Epistem/Genedrive
  • Exalenz Bioscience
  • EY Laboratories
  • FABPulous B.V.
  • Fio Corp
  • Helena Labs
  • Hema Diagnostic System
  • InSilixa
  • Instrumentation Laboratories
  • Jant Pharmacal
  • LamdaGen Corp
  • LifeScan
  • LifeSign
  • Macherey-Nagel
  • Magnasense Technologies
  • Mbio Diagnostics
  • Medix Biochemical
  • MedMira
  • Menarini Diagnostics
  • Meridian BioScience
  • Metaara Medical Technologies
  • Nova Biomedical
  • OPKO Health
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Polymedco
  • Polymer Technologies
  • QuantuMDx Group
  • Quidel
  • Radiometer Medical
  • Response Biomedical
  • Roche Diagnostics
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Siloam Biosciences
  • Spectral Medical
  • Sysmex
  • Trinity Biotech
  • Veredus Laboratories
  • Wave 80 Biosciences
  • Xagenic
Note: Product cover images may vary from those shown
6 of 7
7 of 7
Note: Product cover images may vary from those shown
Adroll
adroll